Find clinical trials in your area
Search by disease and location to discover available clinical trials matching your criteria.
↓
Matched clinical trials
BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI
Not yet recruiting
Investigated drugs:
Study Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer
Not recruiting
Investigated drugs:
+4
Study comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer
Not recruiting
Investigated diseases:Investigated drugs:
Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency
Not recruiting
Investigated diseases:Investigated drugs:
+3
Study of Abemaciclib Combined with Abiraterone and Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Not recruiting
Investigated diseases:Investigated drugs:
+6
Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer
Not recruiting
Investigated diseases:Investigated drugs:
